Global Nutraceutical & Vaccine Market

Nutraceutical & Vaccine Market Size, Share, Growth Analysis, By Type(Nutraceutical and Vaccine), By End-User(Adult and Children), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35I2337 | Region: Global | Published Date: March, 2024
Pages: 202 | Tables: 59 | Figures: 75

Nutraceutical & Vaccine Market Insights

Nutraceutical & Vaccine Market size was valued at USD 57.04 Billion in 2023 and is poised to grow from USD 61.38 Billion in 2024 to USD 110.28 Billion by 2032, growing at a CAGR of 7.60% during the forecast period (2025-2032).

The global nutraceutical and vaccine market has witnessed significant growth in recent years. Nutraceuticals, which encompass functional foods, dietary supplements, and herbal products, are gaining popularity due to their potential health benefits and preventive properties. Rising consumer awareness regarding the importance of nutrition and wellness has fueled the demand for nutraceutical products. On the other hand, the vaccine market has experienced a surge in demand, driven by increased emphasis on disease prevention, advancements in vaccine technology, and expanding immunization programs worldwide. Governments worldwide are committed to ensuring universal access to immunization, regardless of social or economic status. In May 2012, the World Health Organization (WHO) introduced the 'Global Vaccine Action Plan (GVAP),' which received authorization from 194 member states of the World Health Assembly. This plan focuses on strengthening routine immunization to prevent the spread of communicable diseases. Regular assessments are conducted to evaluate progress in meeting national vaccination coverage goals. The involvement of government and non-governmental organizations has become increasingly important in this field, providing a significant boost to the sector. UNICEF and the WHO have published guidelines, such as the comprehensive Multi-Year Plan (cMYP), which aims to ensure equal access to vaccination and increase stakeholder participation. Financial strategies are developed to assess program costs and enhance accountability. The global immunization coverage has steadily increased, leading to a thriving market. In 2014, 115 million infants worldwide received the Diphtheria, Pertussis, and Tetanus (DPT3) vaccine, with approximately 129 countries achieving nearly 90% vaccination coverage for DPT3. Nutraceuticals are products that offer additional nutrition and health benefits to the body. They include fortified nutrients like taurine, CoQ10, omega-3, calcium, zinc, and antioxidants, which contribute to overall well-being. Nutraceuticals are known to prevent various medical conditions, including hypertension, diabetes, heart diseases, and allergies. As consumers increasingly prioritize their health and well-being, the demand for nutraceuticals is rising globally. Consumers believe that proper nutrition can reduce healthcare expenses and social security costs, thereby benefiting governments and promoting a healthier population.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Nutraceutical & Vaccine Market size was valued at USD 57.04 Billion in 2023 and is poised to grow from USD 61.38 Billion in 2024 to USD 110.28 Billion by 2032, growing at a CAGR of 7.60% during the forecast period (2025-2032).

The global nutraceutical and vaccine market is characterized by a diverse range of players, including pharmaceutical companies, biotechnology firms, and food and beverage manufacturers. These companies strive to develop innovative products and technologies to gain a competitive edge. Key strategies employed by market players include product launches, mergers and acquisitions, collaborations, and partnerships to expand their market presence and strengthen their product portfolios. Additionally, investments in research and development activities, clinical trials, and regulatory compliance are crucial for sustaining competitiveness in this dynamic market. 'Pfizer Inc. (US)', 'Johnson & Johnson (US)', 'Novartis International AG (Switzerland)', 'Merck & Co., Inc. (US)', 'GlaxoSmithKline plc (UK)', 'Sanofi S.A. (France)', 'AstraZeneca plc (UK)', 'Abbott Laboratories (US)', 'Eli Lilly and Company (US)', 'Gilead Sciences, Inc. (US)', 'Amgen Inc. (US)', 'Bristol Myers Squibb (US)', 'Moderna, Inc. (US)', 'Roche Holding AG (Switzerland)', 'Novo Nordisk A/S (Denmark)', 'Takeda Pharmaceutical Company Limited (Japan)', 'Bayer AG (Germany)', 'Astellas Pharma Inc. (Japan)', 'Daiichi Sankyo Company, Limited (Japan)', 'AbbVie Inc. (US)'

One significant driver in the global nutraceutical and vaccine market is the increasing emphasis on preventive healthcare. With growing awareness about the importance of maintaining overall well-being and preventing diseases, there is a rising demand for products that offer health benefits and enhance the immune system. Consumers are actively seeking out nutraceuticals and vaccines as part of their proactive approach to healthcare. This driver is fueled by factors such as changing lifestyles, aging populations, and a desire to reduce healthcare costs by preventing illnesses rather than treating them.

One key market trend in the global nutraceutical and vaccine industry is the growing demand for personalized and targeted healthcare solutions. Consumers are increasingly seeking products that cater to their specific health needs and genetic makeup. This trend is fueled by advancements in technologies such as genomics, personalized medicine, and data analytics, which allow for customized nutrition and vaccination approaches. Market players are responding to this trend by developing personalized nutraceuticals and vaccines, offering tailored formulations and treatment plans that address individual health concerns and optimize outcomes. This trend reflects the shift towards precision healthcare and the recognition of individual variations in health requirements.

North America dominated the global nutraceutical and vaccine market, with a significant market share. The region's dominance can be attributed to several factors, including a well-established healthcare infrastructure, robust research and development activities, high consumer awareness about health and wellness, and favorable government regulations. The United States, in particular, plays a crucial role in driving market growth in North America, owing to its strong pharmaceutical industry and extensive vaccine manufacturing capabilities.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Nutraceutical & Vaccine Market

Report ID: SQMIG35I2337

$5,300
BUY NOW GET FREE SAMPLE